应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HIMS Hims & Hers Health Inc.
未开盘 09-09 16:00:00 EDT
27.90
-0.27
-0.96%
盘后
27.83
-0.07
-0.25%
19:59 EDT
最高
28.28
最低
27.27
成交量
844.23万
今开
28.10
昨收
28.17
日振幅
3.59%
总市值
65.09亿
流通市值
59.62亿
总股本
2.33亿
成交额
2.33亿
换手率
3.95%
流通股本
2.14亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|Hims & Hers Health盘中下跌5.01%,Visa监控计划及FTC诉讼持续施压致盘中反弹遇阻
行情直击 · 08-28
异动解读|Hims & Hers Health盘中下跌5.01%,Visa监控计划及FTC诉讼持续施压致盘中反弹遇阻
异动解读|Hims & Hers Health盘中上涨5.53%,Needham上调目标价至42美元叠加超跌反弹
行情直击 · 08-28
异动解读|Hims & Hers Health盘中上涨5.53%,Needham上调目标价至42美元叠加超跌反弹
异动解读|Hims & Hers Health盘中下跌5.12%,Visa监控计划与巴克莱下调目标价持续施压
行情直击 · 08-26
异动解读|Hims & Hers Health盘中下跌5.12%,Visa监控计划与巴克莱下调目标价持续施压
异动解读|Hims & Hers Health盘中下跌6.78%,巴克莱下调目标价叠加信用卡纠纷消息持续施压
行情直击 · 08-24
异动解读|Hims & Hers Health盘中下跌6.78%,巴克莱下调目标价叠加信用卡纠纷消息持续施压
市场消息: HIMS 的减重方案因信用卡纠纷遭到处罚。
智通财经 · 08-22
市场消息: HIMS 的减重方案因信用卡纠纷遭到处罚。
异动解读|Hims & Hers Health盘中上涨5.16%,CEO反击FTC诉讼持续推动股价连日反弹
行情直击 · 08-21
异动解读|Hims & Hers Health盘中上涨5.16%,CEO反击FTC诉讼持续推动股价连日反弹
异动解读|Hims & Hers Health盘中上涨5.21%,CEO公开反击FTC诉讼持续提振市场情绪
行情直击 · 08-20
异动解读|Hims & Hers Health盘中上涨5.21%,CEO公开反击FTC诉讼持续提振市场情绪
异动解读|Hims & Hers Health盘中上涨5.26%,CEO公开反击FTC诉讼提振市场信心
行情直击 · 08-19
异动解读|Hims & Hers Health盘中上涨5.26%,CEO公开反击FTC诉讼提振市场信心
异动解读|Hims & Hers Health盘中下跌7.3%,Q2每股亏损远超预期由盈转亏
行情直击 · 08-11
异动解读|Hims & Hers Health盘中下跌7.3%,Q2每股亏损远超预期由盈转亏
Riot Platforms盘前暴涨逾21%,与Anthropic达成91亿美元算力协议;Rocket Lab USA、USA Rare Earth绩后跌超8%
老虎资讯综合 · 08-11
Riot Platforms盘前暴涨逾21%,与Anthropic达成91亿美元算力协议;Rocket Lab USA、USA Rare Earth绩后跌超8%
盘前异动 | 美股三大股指期货齐跌;Riot签下91亿大单,盘前大涨22%;B&W二季度业绩公布,盘前暴涨39%;Life360、Upwork重挫,跌逾19%
老虎资讯综合 · 08-11
盘前异动 | 美股三大股指期货齐跌;Riot签下91亿大单,盘前大涨22%;B&W二季度业绩公布,盘前暴涨39%;Life360、Upwork重挫,跌逾19%
异动解读|Hims & Hers Health盘前下跌6.37%,Q2每股亏损远超预期由盈转亏
行情直击 · 08-11
异动解读|Hims & Hers Health盘前下跌6.37%,Q2每股亏损远超预期由盈转亏
美股夜盘|Riot Platforms涨26%;新闻集团涨1%;RKLB跌7%;普拉格能源涨6%
美股夜盘 · 08-11
美股夜盘|Riot Platforms涨26%;新闻集团涨1%;RKLB跌7%;普拉格能源涨6%
异动解读|Hims & Hers Health夜盘下跌7.11%,Q2每股亏损远超预期引发市场担忧
行情直击 · 08-11
异动解读|Hims & Hers Health夜盘下跌7.11%,Q2每股亏损远超预期引发市场担忧
异动解读 | Hims & Hers Health夜盘大跌7.08%,Q2财报由盈转亏引发市场担忧
异动解读 · 08-11
异动解读 | Hims & Hers Health夜盘大跌7.08%,Q2财报由盈转亏引发市场担忧
Hims & Hers Q2营收增长38%,上调全年收入指引,但转盈为亏拖累盘后股价
老虎资讯综合 · 08-11
Hims & Hers Q2营收增长38%,上调全年收入指引,但转盈为亏拖累盘后股价
Hims & Hers Health预计毛利率将持续低于历史水平,因国际及减肥业务扩张——电话会议透露
美股速递 · 08-11
Hims & Hers Health预计毛利率将持续低于历史水平,因国际及减肥业务扩张——电话会议透露
Hims & Hers Health提前测试肽类成分,静待FDA关于允许药物配制的决定——电话会议透露
美股速递 · 08-11
Hims & Hers Health提前测试肽类成分,静待FDA关于允许药物配制的决定——电话会议透露
异动解读 | Hims & Hers Health盘后大跌5.25%,Q2财报每股亏损远超预期引发市场担忧
异动解读 · 08-11
异动解读 | Hims & Hers Health盘后大跌5.25%,Q2财报每股亏损远超预期引发市场担忧
Hims & Hers Health:CFO称国际业务与减肥产品拖累Q2利润率
美股速递 · 08-11
Hims & Hers Health:CFO称国际业务与减肥产品拖累Q2利润率
公司概况
公司名称:
Hims & Hers Health Inc.
所属市场:
NYSE
上市日期:
--
主营业务:
Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。
发行价格:
--
{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":27.9,"timestamp":1788984000000,"preClose":28.17,"halted":0,"volume":8442282,"hourTrading":{"tag":"盘后","latestPrice":27.83,"preClose":27.9,"latestTime":"19:59 EDT","volume":274112,"amount":7641289.2877,"timestamp":1788998376716,"change":-0.07,"changeRate":-0.002509,"amplitude":0.005376},"delay":0,"changeRate":-0.009584664536741325,"floatShares":213683495,"shares":233313413,"eps":-0.623,"marketStatus":"未开盘","change":-0.27,"latestTime":"09-09 16:00:00 EDT","open":28.1,"high":28.28,"low":27.27,"amount":233229682.156878,"amplitude":0.035854,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.623,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789027200000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":28.17,"preHourTrading":{"tag":"盘前","latestPrice":28.18,"preClose":28.17,"latestTime":"09:29 EDT","volume":102048,"amount":2875597.019616,"timestamp":1788960574047,"change":0.01,"changeRate":0.000355,"amplitude":0.011005},"postHourTrading":{"tag":"盘后","latestPrice":27.83,"preClose":27.9,"latestTime":"19:59 EDT","volume":274112,"amount":7641289.2877,"timestamp":1788998376716,"change":-0.07,"changeRate":-0.002509,"amplitude":0.005376},"volumeRatio":0.977939,"impliedVol":0.6933,"impliedVolPercentile":0.1036},"requestUrl":"/m/hq/s/HIMS/wiki","defaultTab":"wiki","newsList":[{"id":"1171702853","title":"异动解读|Hims & Hers Health盘中下跌5.01%,Visa监控计划及FTC诉讼持续施压致盘中反弹遇阻","url":"https://stock-news.laohu8.com/highlight/detail?id=1171702853","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171702853?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:57","pubTimestamp":1787925454,"startTime":"0","endTime":"0","summary":"8月28日,Hims & Hers Health盘中下跌5.01%,报30.075美元/股,成交额4730.43万美元。消息面上,尽管Needham将目标价上调至42美元一度提振股价反弹逾5%,但Visa收单机构监控计划的持续影响以及此前FTC起诉公司向Meta、Snap共享用户健康数据等利空,令盘中涨幅迅速回吐。公司因减肥订阅业务信用卡纠纷激增被纳入Visa监控计划,需连续三个月将争议率降至1.5%以下方可退出,叠加巴克莱下调目标价至35美元,合规风险与估值压力持续制约反弹空间。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers盘中下跌,合规风险持续施压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159075180","title":"异动解读|Hims & Hers Health盘中上涨5.53%,Needham上调目标价至42美元叠加超跌反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1159075180","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159075180?lang=zh_cn&edition=full","pubTime":"2026-08-28 03:09","pubTimestamp":1787857770,"startTime":"0","endTime":"0","summary":"8月28日,Hims & Hers Health盘中上涨5.53%,报31.48美元/股,成交额1.91亿美元。消息面上,Needham将公司目标价上调至42美元,Truist此前也将目标价从27美元上调至32美元维持持有评级,多家机构上调目标价提振市场情绪。此前公司因Visa收单机构监控计划及巴克莱下调目标价至35美元,股价在8月24日和26日分别下跌约8%和5%,连续承压后技术性反弹动能积聚。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims获多家机构上调目标价,股价应声上涨","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159569740","title":"异动解读|Hims & Hers Health盘中下跌5.12%,Visa监控计划与巴克莱下调目标价持续施压","url":"https://stock-news.laohu8.com/highlight/detail?id=1159569740","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159569740?lang=zh_cn&edition=full","pubTime":"2026-08-26 23:37","pubTimestamp":1787758623,"startTime":"0","endTime":"0","summary":"8月26日,Hims & Hers Health盘中下跌5.12%,报30.125美元/股,成交额1.2亿美元。同时,巴克莱将公司目标价从39美元下调至35美元,维持\"增持\"评级。Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,提供心理健康、性健康、皮肤病学、头发护理等领域的医疗服务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims股价承压下挫,Visa争议费与目标价下调双重打击","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111936844","title":"异动解读|Hims & Hers Health盘中下跌6.78%,巴克莱下调目标价叠加信用卡纠纷消息持续施压","url":"https://stock-news.laohu8.com/highlight/detail?id=1111936844","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111936844?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:37","pubTimestamp":1787578675,"startTime":"0","endTime":"0","summary":"8月24日,Hims & Hers Health盘中下跌6.78%,报31.0美元/股,成交额4596.52万美元。消息面上,巴克莱将公司目标价从39美元下调至35美元,维持\"增持\"评级。公司需连续三个月将争议率降至交易量的1.5%以下方可退出该计划。Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,提供心理健康、性健康、皮肤病学等领域的医疗服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers盘中下跌,巴克莱下调目标价叠加信用卡纠纷施压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290875","title":"市场消息: HIMS 的减重方案因信用卡纠纷遭到处罚。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661290875?lang=zh_cn&edition=full","pubTime":"2026-08-22 04:49","pubTimestamp":1787345385,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HIYY","HIMZ","HIMY","HIMC","BK4196","THNR","GLAM","HIMS","HMYY","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119616258","title":"异动解读|Hims & Hers Health盘中上涨5.16%,CEO反击FTC诉讼持续推动股价连日反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1119616258","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119616258?lang=zh_cn&edition=full","pubTime":"2026-08-21 23:04","pubTimestamp":1787324699,"startTime":"0","endTime":"0","summary":"8月21日,Hims & Hers Health盘中上涨5.16%,报33.52美元/股,成交额1.21亿美元。管理层连续积极表态持续缓解市场担忧,叠加Needham上调目标价至42美元、Morgan Stanley上调目标价至28美元等利好信号,推动股价延续反弹走势。自7月30日FTC诉讼公布当日暴跌逾12%以来,HIMS已实现连续多日回升。Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims股价连日反弹,CEO反击诉讼提振信心","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139961660","title":"异动解读|Hims & Hers Health盘中上涨5.21%,CEO公开反击FTC诉讼持续提振市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1139961660","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139961660?lang=zh_cn&edition=full","pubTime":"2026-08-20 21:45","pubTimestamp":1787233508,"startTime":"0","endTime":"0","summary":"8月20日,Hims & Hers Health盘中上涨5.21%,报32.695美元/股,成交额7560.57万美元。管理层积极表态持续缓解此前FTC诉讼引发的市场担忧,叠加Needham上调目标价至42美元、Morgan Stanley上调目标价至28美元等利好信号,推动股价延续反弹走势。Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CEO强硬回击FTC诉讼,Hims股价应声上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1133370583","title":"异动解读|Hims & Hers Health盘中上涨5.26%,CEO公开反击FTC诉讼提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1133370583","media":"行情直击","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133370583?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:08","pubTimestamp":1787148521,"startTime":"0","endTime":"0","summary":"8月19日,Hims & Hers Health盘中上涨5.26%,报29.01美元/股,成交额1.03亿美元。消息面上,公司CEO Andrew Dudum当日接受CNBC采访,就此前FTC指控公司向Meta及Snap共享用户健康数据、收费违规及订阅取消障碍等问题进行正面回应。Dudum表示相关指控源于外界对公司商业模式的误解,强调公司是\"积极的颠覆者\",核心目标在于扩大医疗服务可及性。管理层积极表态缓解了此前FTC诉讼引发的市场担忧,叠加近期Needham上调目标价至42美元等利好信号,推动股价反弹。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105269322","title":"异动解读|Hims & Hers Health盘中下跌7.3%,Q2每股亏损远超预期由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=1105269322","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105269322?lang=zh_cn&edition=full","pubTime":"2026-08-11 21:30","pubTimestamp":1786455029,"startTime":"0","endTime":"0","summary":"8月11日,Hims & Hers Health盘中下跌7.3%,报29.52美元/股,成交额4890.46万美元。消息面上,公司发布第二季度财报,每股亏损0.37美元,远超市场预期的0.03至0.05美元亏损,较去年同期每股盈利0.17美元大幅恶化,由盈转亏。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180557150","title":"Riot Platforms盘前暴涨逾21%,与Anthropic达成91亿美元算力协议;Rocket Lab USA、USA Rare Earth绩后跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180557150","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180557150?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:07","pubTimestamp":1786435649,"startTime":"0","endTime":"0","summary":"云计算公司 $Riot Platforms(RIOT)$盘前暴涨逾21%,与Anthropic达成91亿美元算力协议; $Rocket Lab USA, Inc.(RKLB)$、 $USA Rare Earth Inc.(USAR)$跌超8%, $Hims & Hers Health Inc.(HIMS)$ 跌超7%,此前均公布最新业绩。","market":"us","thumbnail":"https://static.tigerbbs.com/8563c55eda230bf12ce63dc5314b95d0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8563c55eda230bf12ce63dc5314b95d0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","RTYY","HIYY","RIOX","RIOT","RKLX","HIMZ","USAX","HIMS","HIMY","RKLB","USGG","RKLZ","USAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164330137","title":"盘前异动 | 美股三大股指期货齐跌;Riot签下91亿大单,盘前大涨22%;B&W二季度业绩公布,盘前暴涨39%;Life360、Upwork重挫,跌逾19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164330137","media":"老虎资讯综合","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164330137?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:04","pubTimestamp":1786435492,"startTime":"0","endTime":"0","summary":"美国股指期货周二齐跌。与道琼斯工业平均指数挂钩的期货跌 0.23%;标普500指数期货微跌 0.01%;纳斯达克100指数期货跌 0.23%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USAR","USAX","RKLB","HIMY","RDW","RKLZ","UPWK","USGG","HIMZ","HIMS","RKLX","HMYY","LIF","RDWU","BW","HIYY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1108432600","title":"异动解读|Hims & Hers Health盘前下跌6.37%,Q2每股亏损远超预期由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=1108432600","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108432600?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:00","pubTimestamp":1786435231,"startTime":"0","endTime":"0","summary":"8月11日,Hims & Hers Health盘前下跌6.37%,报29.57美元/股。但毛利率从去年同期的76%骤降至64%,管理层表示国际业务拓展及品牌GLP-1减肥药销售拖累利润率并产生重组成本。CFO预计毛利率将长期维持在历史低位以下。Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health盘前下跌6.37%,Q2每股亏损远超预期由盈转亏","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118884582","title":"美股夜盘|Riot Platforms涨26%;新闻集团涨1%;RKLB跌7%;普拉格能源涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118884582","media":"美股夜盘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118884582?lang=zh_cn&edition=full","pubTime":"2026-08-11 08:06","pubTimestamp":1786406783,"startTime":"0","endTime":"0","summary":"Riot Platforms涨25.77%,宣布与前沿AI实验室签署为期20年的191兆瓦数据中心租赁,预计总收入91亿美元,推进向AI/HPC转型。SpaceX跌1.59%,SEC就涉及SpaceX的IPO前股票欺诈指控与Adit达成和解,私募二级交易规范化受关注,相关舆情扰动情绪。Hims & Hers Health Inc. 跌6.83%,Q2每股亏损0.37美元远超预期,由盈转亏,管理层称国际拓展与品牌减重药拖累毛利率并产生重组成本。Rocket Lab USA, Inc. 跌7.02%,Q2营收超预期但每股亏损逊预期,且Q3 GAAP毛利率指引29%-31%低于市场预期,Neutron首飞时间或再推迟。","market":"us","thumbnail":"https://static.tigerbbs.com/02ad453d1404f80bdd57419bc97bfad5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/02ad453d1404f80bdd57419bc97bfad5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKLZ","SPCH","HYDR","HIYY","DAPP","USGG","BK4595","BK4096","LOFF","SPCX","CTEX","SPCU","SNK","BK4600","RTYY","SPCG","SPAL","LU2357305700.SGD","RIOX","USAX","FSPC","RKLB","LOFD","BK4111","NWSA","SPCQ","SPCM","HIMY","LFGY","USAR","BK4585","IBLC","LU2249611893.SGD","LU1720051108.HKD","BK4588","SPCF","BK4023","LU1169590202.USD","RKLX","BKCH","BK4615","BK4541","LU1720051017.SGD","RIOT","SSPC","PLUG","HIMZ","BLOX","ELOL","LU1169589451.USD","LU1548497426.USD","HIMS","LU0823414478.USD","BK4187","BK4516","DIPR","PLUL","HMYY","BK4564","SPAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1124935976","title":"异动解读|Hims & Hers Health夜盘下跌7.11%,Q2每股亏损远超预期引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1124935976","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124935976?lang=zh_cn&edition=full","pubTime":"2026-08-11 08:00","pubTimestamp":1786406431,"startTime":"0","endTime":"0","summary":"8月11日,Hims & Hers Health夜盘下跌7.11%,报29.51美元/股。消息面上,公司发布第二季度财报,每股亏损0.37美元,远超市场预期的0.03-0.05美元亏损,较去年同期每股盈利0.17美元大幅恶化,由盈转亏。尽管营收表现亮眼且远期目标乐观,巨额亏损仍令投资者信心承压。Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118453773","title":"异动解读 | Hims & Hers Health夜盘大跌7.08%,Q2财报由盈转亏引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1118453773","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118453773?lang=zh_cn&edition=full","pubTime":"2026-08-11 08:00","pubTimestamp":1786406430,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.在夜盘交易时段股价大跌7.08%,引发市场广泛关注。消息面上,公司发布了第二季度财报。盈利下滑的背后,是公司向品牌GLP-1减肥药转型所带来的压力。公司毛利率从去年同期的76%大幅下降至64%,国际业务拓展及减肥产品销售也对整体利润率形成了拖累。尽管管理层对未来增长抱有信心,但巨额亏损令投资者感到不安,导致夜盘股价承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105273591","title":"Hims & Hers Q2营收增长38%,上调全年收入指引,但转盈为亏拖累盘后股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1105273591","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105273591?lang=zh_cn&edition=full","pubTime":"2026-08-11 07:24","pubTimestamp":1786404286,"startTime":"0","endTime":"0","summary":"财报显示,Hims & Hers第二季度实现营收7.53亿美元,同比增长38%;订阅用户总数增至约289万,同比增长19%;每位订阅用户月均收入达到92美元,同比增长21%,反映用户消费金额持续提升。Hims & Hers将2026年全年营收指引由原先的28亿至30亿美元,上调至31亿至33亿美元;第三季度预计营收为8.8亿至9亿美元,同样高于市场预期。受此影响,Hims & Hers股价在盘后交易中下跌约7%,尽管营收超出市场预期且全年收入指引获得上调。","market":"us","thumbnail":"https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR-qMPbNE-LY2BuQBFt6mZxC79w2Pptk9wS91cqArf44A&s=10","type":0,"news_type":0,"thumbnails":["https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR-qMPbNE-LY2BuQBFt6mZxC79w2Pptk9wS91cqArf44A&s=10"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Q2营收增长38%,上调全年收入指引,但转盈为亏拖累盘后股价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMY","HIMZ","HMYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1103305801","title":"Hims & Hers Health预计毛利率将持续低于历史水平,因国际及减肥业务扩张——电话会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1103305801","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103305801?lang=zh_cn&edition=full","pubTime":"2026-08-11 05:34","pubTimestamp":1786397692,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.在电话会议中透露,由于国际市场的拓展以及减肥业务的扩张,公司预计毛利率将长期维持在历史低位以下。这一趋势打破了以往相对稳定的盈利水平,反映出公司在全球化和新产品线布局上的大胆投入。尽管此举可能短期内压缩利润空间,但高层认为,这是实现长期增长的关键一步。随着业务版图不断延伸,毛利率的波动性或将加剧,从而考验投资者的耐心与信心。然而,管理层强调,这些战略调整旨在捕捉更广阔的市场机遇,而非简单的财务妥协。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","BK4196","HIMS","THNR","HIYY","HIMY","HMYY","HIMZ","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124573842","title":"Hims & Hers Health提前测试肽类成分,静待FDA关于允许药物配制的决定——电话会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1124573842","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124573842?lang=zh_cn&edition=full","pubTime":"2026-08-11 05:20","pubTimestamp":1786396838,"startTime":"0","endTime":"0","summary":"在即将到来的FDA关键决策之前,Hims & Hers Health Inc.已悄然展开肽类成分的测试工作。这家健康科技公司正密切关注监管机构是否允许针对这些药物进行配制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","GLAM","HIMY","HIYY","BK4196","HIMZ","HEAL","HIMS","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132413287","title":"异动解读 | Hims & Hers Health盘后大跌5.25%,Q2财报每股亏损远超预期引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1132413287","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132413287?lang=zh_cn&edition=full","pubTime":"2026-08-11 05:12","pubTimestamp":1786396354,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health Inc.今日盘后股价大跌5.25%,引发市场广泛关注。消息面上,公司发布了第二季度财报。公司第二季度每股亏损0.37美元,远高于市场预期的每股亏损0.03美元,与去年同期每股盈利0.17美元相比,业绩出现了显著恶化,由盈转亏。尽管管理层上调了全年营收预期至31亿至33亿美元,并对国内业务下半年加速增长抱有信心,但巨额亏损仍然引发了投资者的担忧,导致盘后股价承压。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168471363","title":"Hims & Hers Health:CFO称国际业务与减肥产品拖累Q2利润率","url":"https://stock-news.laohu8.com/highlight/detail?id=1168471363","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168471363?lang=zh_cn&edition=full","pubTime":"2026-08-11 04:56","pubTimestamp":1786395415,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 首席财务官坦言,国际业务拓展以及减肥产品的销售,在第二季度拉低了公司的整体利润率。这些领域的运营特征,与核心业务相比,呈现出不同的盈利表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","THNR","GLAM","HIYY","HIMZ","HIMS","HMYY","HEAL","BK4196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0272},{"period":"1month","weight":-0.1218},{"period":"3month","weight":-0.0336},{"period":"6month","weight":0.1264},{"period":"1year","weight":-0.4162},{"period":"ytd","weight":-0.1407}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.098962},{"month":2,"riseRate":0.571429,"avgChangeRate":0.066017},{"month":3,"riseRate":0.428571,"avgChangeRate":0.011001},{"month":4,"riseRate":0.428571,"avgChangeRate":0.018546},{"month":5,"riseRate":0.428571,"avgChangeRate":0.15891},{"month":6,"riseRate":0.714286,"avgChangeRate":0.028446},{"month":7,"riseRate":0.571429,"avgChangeRate":0.034344},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.116029},{"month":9,"riseRate":0.428571,"avgChangeRate":0.060833},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.073266},{"month":11,"riseRate":0.714286,"avgChangeRate":0.187933},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.001486}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}